CTNM Contineum Therapeutics, Inc. Class A Common Stock logo

CTNM Contineum Therapeutics, Inc. Class A Common Stock

Healthcare
$13.86-3.55%ClosedMarket Cap: $518.2M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$16.00

Target (Median)

$16.00

Target Range

$16.00 - $16.00

Upside from current price: 15.4%

Rating Distribution

1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-05-14Morgan StanleymaintainEqual WeightEqual Weight
2026-03-06BairdmaintainOutperformOutperform
2026-01-08Morgan StanleydowngradeEqual WeightOverweight
2025-11-24BairdmaintainOutperformOutperform
2025-11-21RBC CapitalmaintainOutperformOutperform
2025-08-18Morgan StanleymaintainOverweightOverweight
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.81$2.2M5
Sun Dec 31$-1.91$3.4M2
Mon Dec 31$-2.01$22.8M1
Tue Dec 31$-2.42$25.4M1